Hemispherx (HEB) Shares Continue Lower as Traders Question Ampligen Approval
Tweet Send to a Friend
Shares of the volatile Hemispherx BioPharma (AMEX: HEB) are tumbling once again today, adding onto yesterday's 11.8% decline. This morning ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
